FNDC5 and coronary artery disorder: There is evidence that irisin levels are sufficiently lower in patients with T2DM than in non-T2DM patients, regardless of the presence of coronary artery disease (CAD), severity of coronary artery atherosclerotic lesions and development of collaterals [21,22].